367 related articles for article (PubMed ID: 18821291)
1. The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism.
Karazindiyanoğlu S; Cayan S
Aging Male; 2008 Sep; 11(3):146-9. PubMed ID: 18821291
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of sexual function in men with symptomatic benign prostatic hyperplasia].
Shao Q; Song J; Guo YW; Lu WC; Du LD
Zhonghua Nan Ke Xue; 2005 Jul; 11(7):505-7. PubMed ID: 16078666
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study.
Kalinchenko S; Vishnevskiy EL; Koval AN; Mskhalaya GJ; Saad F
Aging Male; 2008 Jun; 11(2):57-61. PubMed ID: 18570056
[TBL] [Abstract][Full Text] [Related]
4. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
[TBL] [Abstract][Full Text] [Related]
5. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement.
Gerstenbluth RE; Maniam PN; Corty EW; Seftel AD
J Androl; 2002; 23(6):922-6. PubMed ID: 12399540
[TBL] [Abstract][Full Text] [Related]
7. The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial?
Black AM; Day AG; Morales A
BJU Int; 2004 Nov; 94(7):1066-70. PubMed ID: 15541129
[TBL] [Abstract][Full Text] [Related]
8. The pathophysiology of lower urinary tract symptoms after brachytherapy for prostate cancer.
Blaivas JG; Weiss JP; Jones M
BJU Int; 2006 Dec; 98(6):1233-7; discussion 1237. PubMed ID: 17125481
[TBL] [Abstract][Full Text] [Related]
9. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
Roehrborn CG; Kaplan SA; Jones JS; Wang JT; Bavendam T; Guan Z
Eur Urol; 2009 Feb; 55(2):472-9. PubMed ID: 18583022
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
11. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
Bach P; Wormland RT; Möhring C; Goepel M
Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067
[TBL] [Abstract][Full Text] [Related]
12. Sexual dysfunction in aging men with lower urinary tract symptoms.
Mehraban D; Naderi GH; Yahyazadeh SR; Amirchaghmaghi M
Urol J; 2008; 5(4):260-4. PubMed ID: 19101901
[TBL] [Abstract][Full Text] [Related]
13. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
Chapple C; Herschorn S; Abrams P; Sun F; Brodsky M; Guan Z
Eur Urol; 2009 Sep; 56(3):534-41. PubMed ID: 19070418
[TBL] [Abstract][Full Text] [Related]
14. A role of intravesical capsaicin instillation in benign prostatic hyperplasia with overactive bladder symptoms: the first reported study in the literature.
Mahawong P; Chaiyaprasithi B; Soontrapa S; Tappayuthapijarn P
J Med Assoc Thai; 2007 Nov; 90(11):2301-9. PubMed ID: 18181311
[TBL] [Abstract][Full Text] [Related]
15. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
[TBL] [Abstract][Full Text] [Related]
16. Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism.
Okada K; Miyake H; Ishida T; Sumii K; Enatsu N; Chiba K; Matsushita K; Fujisawa M
Am J Mens Health; 2018 Sep; 12(5):1403-1408. PubMed ID: 27256990
[TBL] [Abstract][Full Text] [Related]
17. Oral testosterone replacement in Korean patients with PADAM.
Hong JH; Ahn TY
Aging Male; 2002 Mar; 5(1):52-6. PubMed ID: 12040976
[TBL] [Abstract][Full Text] [Related]
18. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
19. Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry.
Rosen RC; Wei JT; Althof SE; Seftel AD; Miner M; Perelman MA;
Urology; 2009 Mar; 73(3):562-6. PubMed ID: 19167031
[TBL] [Abstract][Full Text] [Related]
20. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints.
Permpongkosol S; Tantirangsee N; Ratana-olarn K
J Sex Med; 2010 Nov; 7(11):3765-74. PubMed ID: 20807330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
